Clearmind Medicine (CMND) Institutional Ownership $1.44 -0.05 (-3.36%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Clearmind Medicine (NASDAQ:CMND)CurrentInstitutional OwnershipPercentage96.05%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$60.39KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$85.88K Get CMND Insider Trade Alerts Want to know when executives and insiders are buying or selling Clearmind Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CMND Institutional Buying and Selling by Quarter Clearmind Medicine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2024AdvisorShares Investments LLC128,641$214K0.0%+14.2%7.598% 7/24/2024Cornerstone Wealth Group LLC20,000$34K0.0%N/A1.183% 2/14/2024AdvisorShares Investments LLC92,693$260K0.1%-24.8%5.485% 11/13/2023Warberg Asset Management LLC220,000$35K0.0%N/A3.143% 8/9/2023AdvisorShares Investments LLC123,257$58K0.0%-19.6%1.761% 5/9/2023AdvisorShares Investments LLC153,257$176K0.1%N/A2.189% (Data available from 1/1/2016 forward) CMND Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMND shares? During the previous two years, the following institutional investors and hedge funds held shares of Clearmind Medicine shares: AdvisorShares Investments LLC ($214K), and Warberg Asset Management LLC ($35K), Cornerstone Wealth Group LLC ($34K).Learn more on CMND's institutional investors. What percentage of Clearmind Medicine stock is owned by institutional investors? 96.05% of Clearmind Medicine stock is owned by institutional investors. Learn more on CMND's institutional investor holdings. Which institutional investors have been buying Clearmind Medicine stock? The following institutional investors have purchased Clearmind Medicine stock in the last 24 months: Warberg Asset Management LLC ($220K), AdvisorShares Investments LLC ($169.21K), and Cornerstone Wealth Group LLC ($20K). How much institutional buying is happening at Clearmind Medicine? Institutional investors have bought a total of 409,205 shares in the last 24 months. This purchase volume represents approximately $6.40M in transactions. Which Clearmind Medicine major shareholders have been selling company stock? The following institutional investors have sold Clearmind Medicine stock in the last 24 months: AdvisorShares Investments LLC ($60.56K). How much institutional selling is happening at Clearmind Medicine? Institutional investors have sold a total of 60,564 shares in the last 24 months. This volume of shares sold represents approximately $513.38K in transactions. Related Companies KPRX Institutional Ownership TLPH Institutional Ownership INDP Institutional Ownership ENSC Institutional Ownership SPRC Institutional Ownership BFRI Institutional Ownership CYCN Institutional Ownership EGRX Institutional Ownership ADXN Institutional Ownership NLSP Institutional Ownership This page (NASDAQ:CMND) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
